SCHEMBL2494574

SCHEMBL2494574

CCCCOc1ccccc1[C](c1ccccc1OCCCC)c1ccccc1OCCCC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.60
KMT2A Q03164 3/20 0.60
MAPT P10636 2/20 0.60
MEN1 O00255 2/20 0.60
CYP3A4 P08684 2/20 0.60
NR1I2 O75469 1/20 0.60
CHRM2 P08172 1/20 0.60
ADRA2A P08913 1/20 0.60
OPRK1 P41145 1/20 0.60
HTR2B P41595 1/20 0.60
SLC6A3 Q01959 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
L3MBTL1 Q9Y468 2/20 0.53
TSHR P16473 4/20 0.52
TDP1 Q9NUW8 1/20 0.52
ALDH1A1 P00352 3/20 0.51
THRB P10828 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492279 0.90 LMNA (0.53) LMNAKMT2AMAPTMEN1CYP3A4
SCHEMBL4366626 0.89 LMNA (0.54) LMNAKMT2AMAPTMEN1CYP3A4
SCHEMBL4365539 0.89 LMNA (0.54) LMNAKMT2AMAPTMEN1CYP3A4
SCHEMBL9898531 0.85 LMNA (0.66) LMNAKMT2AMAPTMEN1CYP3A4
SCHEMBL11302011 0.84 LMNA (0.53) LMNAKMT2AMAPTMEN1CYP3A4
SCHEMBL301123 0.83 KMT2A (0.69) LMNAKMT2AMAPTMEN1CYP3A4
SCHEMBL8154526 0.83 LMNA (0.74) LMNAKMT2AMAPTMEN1CYP3A4
SCHEMBL5034596 0.83 LMNA (0.55) LMNAKMT2AMAPTMEN1CYP3A4
SCHEMBL29994009 0.83 KMT2A (0.69) LMNAKMT2AMAPTMEN1CYP3A4
SCHEMBL50006 0.83 LMNA (0.64) LMNAKMT2AMAPTMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH LMNA 2547/4885KMT2A 2108/4885MAPT 3454/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 LMNA 2843/4885KMT2A 2219/4885MAPT 3294/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R LMNA 2187/4885KMT2A 2287/4885MAPT 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.